Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting
vivani | July 29, 2022
Read More
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
vivani | July 18, 2022
Read More
Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®
vivani | April 14, 2022
Read More
Blog Navigation
Contact Us
To learn more about Vivani, and to learn more about our strategic focus on NPM-139 (semaglutide implant), please fill out this form.